Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder Cancer
Completed
National Cancer Institute (NCI)
Phase 3
2001-09-01
RATIONALE: Diagnostic procedures such as cystoscopy may improve the ability to detect cancer
and to determine the extent of disease.
PURPOSE: Diagnostic trial to compare the effectiveness of cystoscopy using hexyl
5-aminolevulinate and two light sources in detecting carcinoma in situ in patients who have
bladder cancer.
Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder Cancer
Completed
Photocure
Phase 3
2001-09-01
RATIONALE: Diagnostic procedures such as cystoscopy may improve the ability to detect cancer
and to determine the extent of disease.
PURPOSE: Diagnostic trial to compare the effectiveness of cystoscopy using hexyl
5-aminolevulinate and two light sources in detecting carcinoma in situ in patients who have
bladder cancer.
Early Detection of Polyps and Colon Cancer by Fluorescence Imaging - a Dose-finding Study
Completed
KARL STORZ Endoscopy-America, Inc.
Phase 1/Phase 2
2006-07-01
Patients referred for colon inspection (colonoscopy) due to suspicion of colon polyps/cancer
will receive local administration of hexaminolevulinate (HAL) prior to colon inspection. Blue
light illumination will induce red fluorescence of polyps and tumours, improving detection of
the polyps and tumors. Different HAL doses will be tested to find the optimal image
conditions. Tolerability measurements will be performed to ensure patient safety.
Early Detection of Polyps and Colon Cancer by Fluorescence Imaging - a Dose-finding Study
Completed
Photocure
Phase 1/Phase 2
2006-07-01
Patients referred for colon inspection (colonoscopy) due to suspicion of colon polyps/cancer
will receive local administration of hexaminolevulinate (HAL) prior to colon inspection. Blue
light illumination will induce red fluorescence of polyps and tumours, improving detection of
the polyps and tumors. Different HAL doses will be tested to find the optimal image
conditions. Tolerability measurements will be performed to ensure patient safety.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
